- Mallinckrodt Presents New TERLIVAZ® (terlipressin) for Injection Data on Hepatorenal Syndrome (HRS) Reversal at the Society of Critical Care Medicine (SCCM) 2023 Critical Care Congress
- Mallinckrodt Announces 2022 Advancing Extracorporeal Photopheresis Immunomodulation Investigator Award
- Mallinckrodt plc Reports Third Quarter 2022 Financial Results and Reaffirms Guidance
Key statistics
On Monday, Mallinckrodt PLC (MNK:ASQ) closed at 7.35, 7,250.00% above the 52 week low of 0.10 set on Jun 17, 2022.
52-week range
Markit short selling activity
Open | 7.52 |
---|---|
High | 7.53 |
Low | 7.35 |
Bid | 5.38 |
Offer | 9.62 |
Previous close | 7.60 |
Average volume | 59.13k |
---|---|
Shares outstanding | 13.17m |
Free float | 13.04m |
P/E (TTM) | -- |
Market cap | 100.10m USD |
EPS (TTM) | -44.95 USD |
Data delayed at least 15 minutes, as of Jan 30 2023 21:00 GMT.
More ▼